The chemical substance known as "4H-1-Benzopyran-4-one, 3,5-dihydroxy-2-[3-hydroxy-4-(phenylmethoxy)phenyl]-7-(phenylmethoxy)-" with CAS number 13459-13-7 is a complex organic compound characterized by its polyphenolic structure. It features a benzopyran core, which is a fused ring system consisting of a benzene ring and a pyran ring. The presence of multiple hydroxyl groups (dihydroxy) indicates potential for hydrogen bonding and increased solubility in polar solvents. The compound also contains phenylmethoxy substituents, which can enhance its lipophilicity and influence its biological activity. Such compounds are often studied for their antioxidant properties and potential therapeutic applications, particularly in the fields of pharmacology and medicinal chemistry. The intricate arrangement of functional groups suggests that it may exhibit diverse interactions with biological targets, making it a subject of interest in drug development and natural product chemistry. Its stability, reactivity, and solubility characteristics would depend on the specific conditions under which it is studied.

4H-1-Benzopyran-4-one, 3,5-dihydroxy-2-[3-hydroxy-4-(phenylmethoxy)phenyl]-7-(phenylmethoxy)-

13459-13-7: The chemical substance known as "4H-1-Benzopyran-4-one, 3,5-dihydroxy-2-[3-hydroxy-4-(phenylmethoxy)phenyl]-7-(phenylmethoxy)-" with CAS number 13459-13-7 is a complex organic compound characterized by its polyphenolic structure. It features a benzopyran core, which is a fused ring system consisting of a benzene ring and a pyran ring. The presence of multiple hydroxyl groups (dihydroxy) indicates potential for hydrogen bonding and increased solubility in polar solvents. The compound also contains phenylmethoxy substituents, which can enhance its lipophilicity and influence its biological activity. Such compounds are often studied for their antioxidant properties and potential therapeutic applications, particularly in the fields of pharmacology and medicinal chemistry. The intricate arrangement of functional groups suggests that it may exhibit diverse interactions with biological targets, making it a subject of interest in drug development and natural product chemistry. Its stability, reactivity, and solubility characteristics would depend on the specific conditions under which it is studied.

<p>RuDiOBn exhibits low antioxidant activity by scavenging DPPH and ABTS free radicals with scavenging rates of 13.2% and 5.9% at a concentration of 100 μg/mL. It inhibits collagen glycation and reduces the formation of advanced glycation end-products (AGE) with an IC50 of 2.45 μg/mL. RuDiOBn also enhances fibroblast proliferation and migration, stimulates collagen synthesis, and aids in skin repair and regeneration while inhibiting collagenase.</p>

CAS 13459-13-7

4H-1-Benzopyran-4-one, 3,5-dihydroxy-2-[3-hydroxy-4-(phenylmethoxy)phenyl]-7-(phenylmethoxy)-

RuDiOBn

Ref: TM-T206205